Examples
Worked examples
- Is an instance
A chemically defined, animal-component-free production medium used to culture a CHO cell line manufacturing a therapeutic monoclonal antibody, selected specifically because its documented raw-material sourcing supports a regulatory submission.
- Is an instance
A lab replacing a serum-supplemented maintenance medium with a chemically defined basal formulation to eliminate the recurring FBS lot-qualification cycle, after confirming through a bridging growth study that the cell line performs comparably.
Counter-examples
Looks similar, but isn't
- Not an instance
A medium labeled 'serum-free' that still contains a non-recombinant animal-derived protein or an undefined plant hydrolysate -- serum-free is not the same claim as chemically defined, and the label alone doesn't confirm full compositional disclosure.
- Not an instance
Fetal bovine serum-supplemented basal medium -- a complex, undefined biological component whose presence, in any concentration, disqualifies a formulation from being chemically defined regardless of how well-characterized the rest of the medium is.
Editorial commentary
Chemically defined media (CDM) is a cell-culture growth medium in which the identity and concentration of every ingredient is known and controlled — no undefined animal-derived components such as serum, hydrolysates, or extracts. Each nutrient, salt, amino acid, vitamin, lipid, and growth factor in a chemically defined formulation is a specific, characterized chemical entity (increasingly supplied as a recombinant protein rather than an animal-purified one), added at a documented concentration. That total traceability is what distinguishes CDM from serum-supplemented (complex) media, and it is also what makes CDM a distinct procurement and qualification category from the broader “serum-free” or “animal-component-free” (ACF) labels a supplier might use.
For a lab manager, procurement officer, or QA lead sourcing media for a cell line, hybridoma, or bioprocess, the practical question is rarely “what is CDM” in the abstract — it’s whether a specific product on a specific vendor’s catalog actually meets that definition, and what documentation you need in hand before you can rely on it for a regulated or GMP-adjacent process. This page covers both.
What makes a medium “chemically defined”
A formulation earns the “chemically defined” label only when it satisfies all of the following:
- Every component is a known chemical entity. Inorganic salts, buffers, a defined carbon source, amino acids, vitamins, trace elements, and lipids are each individually specified — not supplied as part of an undefined mixture.
- Concentrations are documented, not just ingredients. A supplier’s certificate of analysis (CoA) should state the quantitative composition, not merely list what’s present.
- Protein supplements, where used, are purified or recombinant, and identified. Growth-promoting proteins such as albumin, transferrin, or insulin-like growth factor are supplied as characterized recombinant proteins (commonly expressed in yeast, E. coli, or plant systems) rather than as components of an animal-derived extract.
- No component is an undefined biological fluid or hydrolysate. Fetal bovine serum, bovine or porcine hydrolysates, and plant peptone digests are all complex mixtures of thousands of unidentified molecules that vary lot to lot — their presence, in any amount, disqualifies a medium from being chemically defined, even if the medium is otherwise “serum-free.”
Chemically defined media vs. complex media
The distinction procurement teams most often need to explain internally — to a PI, a QA reviewer, or an auditor — is CDM versus complex (serum-containing) media:
| Dimension | Chemically defined media | Complex media (e.g., serum-supplemented) |
|---|---|---|
| Composition | Every component individually identified and quantified | Includes at least one undefined biological component (serum, hydrolysate, extract) |
| Lot-to-lot consistency | High — formulation is reproducible from raw-material specifications | Variable — each serum or hydrolysate lot differs biologically and typically requires qualification testing before use |
| Adventitious-agent risk | Substantially reduced (no animal-sourced biological fluid in the formulation) | Present — serum carries a documented, if managed, risk of viral, mycoplasma, and prion contamination |
| Regulatory documentation burden | Lower per lot once the formulation and raw-material sourcing are qualified — components are traceable to certificates of analysis | Higher — each serum lot generally needs its own qualification (growth-promotion testing, viral and mycoplasma testing, geographic-sourcing/BSE-risk documentation) |
| Typical cost driver | Cost concentrated in recombinant protein components and formulation complexity | Serum itself is frequently the single largest raw-material cost in a culture process |
| Ethical/sourcing considerations | No live-animal collection step in the supply chain | Fetal bovine serum sourcing has drawn sustained scrutiny over fetal-collection practices |
Examples of chemically defined media
“Chemically defined” is a compositional standard, not a single product — it applies across formulation families used for different purposes:
- Chemically defined basal formulations built on classic backbones (e.g., DMEM/F-12-derived or CD-prefixed commercial lines) with serum replaced entirely by recombinant proteins and defined lipid/vitamin supplements, used for routine maintenance of established, serum-adapted cell lines.
- Chemically defined production media for bioprocessing, formulated specifically for CHO, HEK293, or other industrial cell lines used in monoclonal antibody and recombinant protein manufacturing, where lot-to-lot consistency and a documented raw-material chain are direct GMP requirements rather than a convenience.
- Chemically defined, animal-component-free (ACF) formulations for cell and gene therapy, where regulatory expectations (e.g., under ICH Q5D principles on characterization and qualification of cell substrates) push manufacturers toward eliminating animal-derived raw materials from the entire process, not just the growth step.
- Defined microbial and hybridoma media, used in synthetic biology and antibody-production contexts where reproducibility across labs or manufacturing sites is the primary driver.
Not every product marketed as “serum-free” meets this bar. A serum-free medium can still contain an undefined plant hydrolysate or a non-recombinant animal-derived protein and therefore not qualify as chemically defined — check the CoA and formulation disclosure rather than relying on the marketing label alone.
What to evaluate before buying
Because “chemically defined” describes a documentation standard as much as a formulation, procurement due diligence should confirm the following before a product is qualified for use, particularly for a GMP-adjacent or clinical-manufacturing application:
- Full quantitative formulation disclosure. Request the certificate of analysis and, where available, the complete quantitative composition — not just an ingredient list. Some suppliers treat exact formulations as proprietary; confirm what level of disclosure your compliance framework requires before selecting a product on that basis alone.
- Recombinant-protein sourcing and expression system. If the medium includes recombinant albumin, transferrin, or growth factors, document the expression host (yeast, bacterial, or plant) and the supplier’s purification and characterization process.
- Change-control and lot-release documentation. Ask how the supplier notifies customers of formulation or raw-material-source changes, and what lot-release testing (identity, endotoxin, sterility, growth-promotion performance) accompanies each shipment.
- Manufacturing quality system. For GMP or near-GMP use, confirm the medium is manufactured under an appropriate quality system (e.g., ISO 13485 or cGMP-compliant manufacture, depending on downstream application) and that the supplier can provide the supporting documentation on request — not just a general quality statement on the product page.
- Cold-chain and storage requirements. Many liquid CDM formulations are temperature-sensitive; confirm shipping conditions, shelf life, and freeze-thaw stability data before committing to a supply schedule.
- Regulatory support files. For clinical or commercial manufacturing, ask whether the supplier provides a drug master file (DMF) reference, biological safety data, or a letter of animal-origin-free (AOF) status that your own regulatory submission can cite.
These are evaluation criteria, not a ranking of specific vendors — the right supplier for a given process depends on your cell line, scale, and regulatory pathway, and should be confirmed against the supplier’s own current documentation rather than assumed from a product name.
Why this matters for supply-chain and compliance planning
Chemically defined media reduces two forms of supply risk that complex media carries: biological lot-to-lot variability (each new serum lot can behave differently in culture, forcing a qualification cycle before it can be used in a validated process) and adventitious-agent risk from an animal-sourced raw material. For labs running validated or regulated processes, switching from a serum-containing to a chemically defined formulation is itself a change that typically requires re-qualification — growth-curve comparability, product-quality attribute comparison for a bioprocess, or a documented bridging study — so the decision belongs in a change-control record, not a routine reorder.
Frequently asked questions
What is chemically defined media?
It is a cell-culture medium in which every component — salts, amino acids, vitamins, lipids, and any protein supplements — is a known, individually specified chemical entity at a documented concentration, with no undefined biological components such as serum, hydrolysates, or extracts.
What are examples of chemically defined media?
Common categories include chemically defined basal media for routine maintenance of serum-adapted cell lines, chemically defined production media formulated for industrial cell lines (CHO, HEK293) used in biomanufacturing, animal-component-free formulations built for cell and gene therapy manufacturing, and defined microbial or hybridoma media used where cross-lab reproducibility matters most. Specific commercial product names vary by supplier and cell-line application; confirm formulation details against the current CoA rather than the product name alone.
Chemically defined media vs. complex media — what’s the practical difference for a buyer?
Complex (serum-containing) media requires per-lot qualification testing because each serum lot varies biologically and carries adventitious-agent risk; chemically defined media, once its formulation and raw-material sourcing are qualified, offers materially more consistent lot-to-lot performance and a lower ongoing per-lot documentation burden, at the tradeoff of typically higher raw-material cost for the recombinant protein components and, for some cell lines, an adaptation period to wean the culture off serum dependency.
Is “serum-free” the same thing as “chemically defined”?
No. Serum-free means the medium contains no serum, but it can still include other undefined animal- or plant-derived components (hydrolysates, extracts, non-recombinant purified proteins). Chemically defined is the stricter standard: every component, not just serum, must be individually identified and quantified.
See also: Fetal Bovine Serum (FBS) for the complex-media comparison point referenced above.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Chemically Defined Media (CDM)"
vocab-term-identifier="https://casrai.org/dictionary/term/chemically-defined-media" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/chemically-defined-media",
"name": "Chemically Defined Media (CDM)",
"identifier": "https://casrai.org/dictionary/term/chemically-defined-media",
"description": "Chemically defined media (CDM) is a cell-culture growth medium in which every component -- salts, amino acids, vitamins, lipids, and any protein supplements -- is a known, individually specified chemical entity added at a documented concentration, with no undefined biological components such as serum, hydrolysates, or tissue extracts. A formulation qualifies as CDM only when its full composition is disclosed and quantified, protein supplements (if present) are purified/recombinant and identified by expression source, and no ingredient is an undefined animal- or plant-derived mixture -- a medium that is merely 'serum-free' does not automatically meet this bar if it still contains an undefined hydrolysate or extract.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/compliance-regulatory#set",
"url": "https://casrai.org/dictionary/term/chemically-defined-media",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-08-15T18:13:21",
"inLanguage": "en"
}
